Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

• Status: Completed
• Trial end date: 2004-06-15
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy and safety of an approved drug on asthma symptoms in patients with chronic asthma which is also active during the allergy season.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Asthma symptoms brought on by allergies

Exclusion Criteria:

• Patient has any lung disease

• Currently have a sinus infection or cold symptoms